百勝中國-S(09987.HK)接獲港交所有關主要上市轉換計劃申請的收悉確認
格隆匯8月15日丨百勝中國-S(09987.HK)公吿,公司申請將其在香港聯合交易所有限公司主板第二上市地位自願轉為主要上市。於2022年8月15日,公司接獲港交所有關主要上市轉換計劃申請的收悉確認。
主要上市轉換計劃的生效日期預計為2022年10月24日。公司在兩家交易所的普通股將可繼續完全互換,投資者亦可以繼續選擇在任一證券交易所買賣其股份。
百勝中國首席執行官屈翠容表示:“自2020年在香港第二上市以來,公司加強了與亞洲股東的聯繫。公司亦擴大了投資者基礎及開闢了額外的資金池。雙重主要上市將進一步拉近公司與員工、顧客和其他利益相關者的距離。這一戰略舉措使我們能觸達更多投資者、增加股票流動性並降低從紐交所退市風險對公司的影響。展望未來,公司對在中國的長期發展前景倍感振奮,並將繼續致力於打造一家更強大、更具韌性和創新力的公司”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.